Heart attack patients receiving treatment based on electronic order sets of evidence-based care (AMI-OS) experience lower mortality rates, according to a study in the Journal of Hospital Medicine.
Researchers retrospectively analyzed data of 5,879 heart attack patients at 21 community hospitals admitted over 27 months. Approximately 60 percent of those patients (3,531) were treated using AMI-OS.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Fifty percent of AMI-OS treated patients received all five evidence-based therapies indicated in the AMI-OS (aspirin, beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, anticoagulation therapy and statins). Only 35.9 percent of patients receiving individually ordered, or "a la carte," treatments received all five therapies.
The patients treated using AMI-OS experienced a 46 percent lower in-hospital mortality rate than patients receiving individual treatments (3.51 percent vs. 6.52 percent) and a 33 percent lower 30-day mortality rate (5.66 percent vs. 8.48 percent).
Researchers suggest using the electronic order set improves adherence to evidence-based care, as well as better patient outcomes.
More Articles on Quality:
Study: Diabetes, Age Predict Cardiovascular Procedure Complications
High Transfer Rates Not Associated With Higher Mortality
When Crossing Boundaries Helps Patients Stay Healthy